Posters

From high-volume, low-cost to personalized high-tech cataract surgery: high tech and new organization benefit vs surgeon traditional experience

Poster Details

First Author: M.Piovella ITALY

Co Author(s):    G. Scaltrini                    

Abstract Details

Purpose:

A new generation of high-tech IOLs (HTI) for distance, intermediate and near correction in cataract eyes is now available, i.e. trifocal, pinhole and extended depth of focus. For best results and adequate patient satisfaction, a structured approach is mandatory.

Setting:

C.M.A. Centro Microchirurgia Ambulatoriale Monza – Italy

Methods:

According to our experience, mandatory factors for success with HTI are: accurate eyes selection excluding those with amblypia or motility and reading difficulties; accurate biometry is the most important key point : emmetropia was intensively pursued. Dry eye detection and management; contrast sensitivity measurement. Patients were informed about advanced technologies IOL performance based on different contrast sensitivity, light distribution, and light loss. We measured UDVA, UIVA, and UNVA. Patients were inquired about preoperative and postoperative halo and glare perception

Results:

A structured approach was adopted in all patients undergoing bilateral cataract surgery and implantation of HTI aiming at good distance intermediate and near vision. Comparing results obtained in cohorts of patients receiving, alternatively, trifocal, pinhole and extended depth of focus, we achieved similar percentages of patient satisfaction and comparable, despite the different technologies, satisfactory UNVA, UIVA and UNVA

Conclusions:

A structured method to select, measure, prepare, calculate and implant HTI, provided the possibility to implant HTI in over 50% of cataract patients. Adoption and best management of most advanced technologies is mandatory.

Financial Disclosure:

receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented